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1362Objective: Pulmonary arteriovenous malformations are an important but uncommon complication of cavopul-
monary connection, particularly in patients with heterotaxy. Absence of hepatic venous effluent in pulmonary
arterial blood seems to be a predisposing factor. Pulmonary arteriovenous malformations are most common after
superior cavopulmonary anastomosis, but may develop, progress, or persist in 1 lung after Fontan completion if
hepatic venous blood streams completely or primarily to the contralateral lung.
Methods: Among 53 patients with heterotaxy and inferior vena cava interruption who underwent a modified
Fontan procedure from 1985 to 2005, 8 had unilateral streaming of hepatic venous flow and clinically significant
pulmonary arteriovenous malformations after hepatic venous inclusion and underwent reconfiguration of the
cavopulmonary pathway. In all 8 patients, the hepatic vein-pulmonary artery pathway was contralateral to
and offset from the pulmonary artery anastomosis of the single or dominant superior vena cava. Pathway recon-
figuration included pulmonary arterial stenting (n ¼ 2), revision of the superior vena cava-pulmonary artery
connection (n ¼ 1), construction of a branched hepatic vein-pulmonary artery conduit (n ¼ 2), and surgical
or transcatheter construction of a direct hepatic vein-azygous vein pathway (n ¼ 5).
Results:Hepatic vein-azygous vein connection led to improvement in 4 of 5 patients; other approaches typically
did not lead to improvement.
Conclusions: Resolution of hypoxemia after cavopulmonary pathway reconfiguration in patients with unilateral
pulmonary arteriovenous malformations and hepatic venous flow-streaming after Fontan completion supports
the importance of hepatic venous effluent in the pathogenesis of pulmonary arteriovenous malformations and
the practice of cavopulmonary pathway revision in such patients. Completion or reconfiguration of the Fontan
circulation with direct hepatic vein-azygous vein connection may provide the most reliable mixing and bilateral
distribution of hepatic venous blood in this population of patients. (J Thorac Cardiovasc Surg 2011;141:1362-70)Supplemental material is available online.
Intrapulmonary right-to-left shunting through pulmonary
arteriovenous malformations (PAVMs) is an important but
uncommon consequence of cavopulmonary connection for
palliation of functionally univentricular heart disease.1 Pa-
tients with heterotaxy and associated interruption of the in-
ferior vena cava (IVC) seem to be at particularly high risk
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The Journal of Thoracic and Cardiovascular Surthe cause of PAVMs in patients with a bidirectional
superior cavopulmonary anastomosis (bidirectional Glenn,
hemi-Fontan, or Kawashima procedure; BCPA) or modified
Fontan circulation (total cavopulmonary connection) is
unknown, it is widely believed that absence of hepatic ve-
nous (HV) effluent in pulmonary arterial (PA) blood flow
is a predisposing factor, particularly in patients with IVC
interruption and the polysplenia form of heterotaxy syn-
drome.2,5,6 The putative agent responsible for suppressing
PAVMs has not been identified, but there is increasing
evidence to support the ‘‘hepatic factor’’ hypothesis. For
example, a growing literature documents the resolution of
PAVMs after restoration of HV blood flow to the affected
lung(s) in patients with a cavopulmonary connection.
Such situations include completion of a modified Fontan
in patients with a BCPA and PAVMs,2,3,7-11 creation of
a brachial arteriovenous fistula in patients with PAVMs
after a unidirectional (or classic) Glenn operation,12 correc-
tion of PA discontinuity in patients with a unidirectional
Fontan connection and PAVMs in the lung receiving only
superior vena cava (SVC) flow,13 and cardiac transplant in
patients with a BCPA or Fontan and PAVMs.14,15gery c June 2011
Abbreviations and Acronyms
BCPA ¼ bidirectional superior cavopulmonary
anastomosis
ePTFE ¼ expanded polytetrafluoroethylene
HV ¼ hepatic vein/venous
IVC ¼ inferior vena cava
PA ¼ pulmonary artery/arterial
PAVM ¼ pulmonary arteriovenous malformation
SVC ¼ superior vena cava
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DAs we and others have reported, PAVMs may persist in 1
lung after inclusion of HV effluent in the PA circulation if
the HV blood streams completely or primarily to the contra-
lateral lung.2,3,16-18 There are also reports of PAVMs
appearing after Fontan completion in the setting of HV
flow-streaming, even if they were not present or clinically
important after BCPA.5,19,20 The purpose of this study
was to review our experience with newly diagnosed
(hereafter, ‘‘new’’) or persistent PAVMs after a modified
Fontan procedure in patients with heterotaxy, interrupted
IVC, and functionally univentricular heart disease, with
a focus on the impact of the anatomic construction and
flow dynamics of the cavopulmonary circulation.MATERIALS AND METHODS
Patients
We reviewed the records of patients with complex univentricular heart
disease associated with heterotaxy and interruption of the IVC who under-
went total cavopulmonary connection from 1985 to 2005. The study was
performed in accordance with a protocol approved by the Committee for
Clinical Investigation at Children’s Hospital Boston. Among 53 patients
meeting these criteria, 8 (15%) were found to have unilateral streaming
of HV flow and persistence or new development of clinically significant
PAVMs after completion of the Fontan circulation and are included in
this study. Four other patients were known to have bilateral PAVMs after
Fontan completion without evidence of HV flow streaming and are not in-
cluded in this report. One of these patients had a type I portosystemic ve-
nous connection, and the other 3 patients had large and extensive PAVMs
before Fontan completion that did not improve after HV inclusion. In
this report, unless otherwise noted, the term ‘‘azygous vein’’ refers nonspe-
cifically to the dominant azygous or hemiazygos vein that carries lower
body venous return to the SVC.
All 8 study patients had interruption of the suprarenal IVC with azy-
gous continuation to a left or right SVC. In 5 patients with bilateral
SVC, the SVC receiving azygous flow was considered the ‘‘dominant’’
SVC. Total cavopulmonary connection (completion Fontan) was per-
formed after bilateral BCPA in 5 patients, after unilateral BCPA in 2 pa-
tients, and without an intermediate BCPA in 1 patient with a single
SVC. The median duration from BCPA to Fontan completion was 2.6
years (0.8–8.3 years). The modified Fontan procedure consisted of a 13-
to 16-mm extracardiac expanded polytetrafluoroethylene (ePTFE) conduit
from the HVs to the left or right PA in 5 patients, an intracardiac lateral
tunnel modified Fontan procedure in 2 patients, and a modified right
atrium-to-PA connection in 1 patient (Table 1). In 3 patients, the conduit
or lateral tunnel was fenestrated. In all 8 patients, the HV-PA pathway
was contralateral to the single or dominant SVC-PA anastomosis, withThe Journal of Thoracic and Cara lateral offset (segment of PA between HV-PA and SVC-PA anastomoses)
that measured at least 1 to 1.5 cm.
Pulmonary Arteriovenous Malformations
Bilateral PAVMs after BCPA and before Fontan were diagnosed in 5 of
the 8 patients. The other 3 patients, 1 of whom did not undergo intermediate
BCPA, were first noted to have clinically important PAVMs after Fontan
completion, based on progressive cyanosis at rest and with exercise. In
the 5 patients with PAVMs after BCPA, completion of the Fontan improved
arterial saturations from a median of 70% to 83%, and led to resolution of
PAVMs in the lung receiving HV flow. However, the PAVMs persisted in
the contralateral lung. In all 3 patients with new PAVMs after Fontan, there
were unilateral PAVMs contralateral to the lung receiving HV flow.
All patients had HV flow-streaming and unilateral PAVMs documented
2.2 to 9.8 years (median 5.0 years) after Fontan completion by cardiac cath-
eterization and angiography (Figures 1–4), at which time resting systemic
arterial oxygen saturations ranged from 75% to 86% (median 83%). In the
patients with newly diagnosed PAVMs after Fontan completion, saturations
were lower at the time of diagnosis than they were pre-Fontan. In all 3 pa-
tients with fenestrated HV-PA connections, the fenestrations had previ-
ously been closed. All patients reported pronounced exercise limitation,
with exacerbation of cyanosis and dyspnea, and 3 (patients 5, 6, 7) were
documented to have exacerbation of hypoxemia during submaximal
exercise testing, with saturations decreasing by 7% to 14%, to as low as
61% in 1 patient.
Cavopulmonary Pathway Modification
In all 8 patients, the geometry of the total cavopulmonary connection
was modified in an effort to redistribute HV flow and treat the PAVMs,
a median of 8.3 years (3.6–10.1 years) after the initial Fontan procedure
(Table 1). A variety of strategies for HV-PA pathway modification were
used, and in 3 patients, multiple modifications were performed. Before
pathway modification, 3 patients underwent a brachial arteriovenous fis-
tula,12 without improvement, and 3 patients had PAVMs embolized with
coils, with minor improvement in saturations.
Patient 1
In patient 1, who had bilateral SVCs, the hypoplastic central PA seg-
ment was stented. There was improvement in the distribution of HV blood
flow after stenting, with substantial flow going to the lung previously un-
perfused by HV effluent. However, the PAVMs in the affected lung were
severe (Figure 1), and hypoxemia persisted without substantial improve-
ment. This patient underwent coil occlusion of large PAVMs at the
same procedure as PA stenting and was listed for heart transplant 2 years
later.
Patient 2
In patient 2, who had a single SVC, central PA stenting was also per-
formed. This did not change the HV flow distribution, and there was pro-
gression of hypoxemia and PAVMs (Figure 2) leading to additional
pathway modifications. This patient subsequently had a second ePTFE
conduit placed between the first conduit and the lung with persistent
PAVMs, in effect creating a bifurcated graft from the HV to bilateral
PAs, but the second graft rapidly thrombosed. The occluded conduit was
recanalized and stented in the catheterization laboratory, and the PA end
of the original conduit was partially occluded with a septal occlusion de-
vice in an attempt to redistribute blood through the stented graft and to
the lung with PAVMs. This patient was severely hypoxemic at the time
of the procedure and died 1 month later.
Patient 3
Patient 3 also underwent placement of a second ePTFE conduit between
the first conduit and the lung with persistent PAVMs to create a bifurcateddiovascular Surgery c Volume 141, Number 6 1363
TABLE 1. Limited summary of patient data
Fontan pathway modifications
Patient
no.
Original Fontan
connection
SPO2 before most
recent pathway
modification
Central
PA
stent
HV-azygous
vein
connection
Other
Fontan
rerouting
PAVM
coil
occlusion
Clinical
improvement
Follow-up
duration
(y)
SPO2 at
most recent
follow-up
1 Left LT 83 X X Minimal 2.1 86
2 HV-RPA ECC 16 mm 80 X Branched HV-PA conduit X No 0.2 Deceased
3 HV-LPA ECC 14 mm 84 X Branched HV-PA conduit Substantial 4.0 96
4 Right RA-PA 85 SVC-PA connection moved Modest 13.1 90
5 HV-RPA ECC 16 mm 86 X Substantial 1.0 97
6 HV-RPA ECC 16 mm 80 X Substantial 1.8 91
7 Right LT 75 X Substantial 0.2 87
8 LHV-LPA ECC 13 mm 83 X X No 3.5 Deceased
ECC, Extracardiac conduit; FU, follow-up; LPA, left pulmonary artery; LT, lateral tunnel; RPA, right pulmonary artery; SPO2, systemic arterial oxygen saturation by pulse
oximetry.
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DHV-bilateral PA graft. As in patient 2, the second graft rapidly thrombosed.
Attempts to recanalize the new graft in the catheterization laboratory were
unsuccessful, and the graft remained occluded. This patient subsequently
had a conduit placed from the HV to the azygous vein, both of which
were located just about in the midline. Through a left-sided posterolateral
thoracotomy without cardiopulmonary bypass, the left inferior pulmonary
ligament was divided, the esophagus was mobilized, and a 12-mm ePTFE
tube was sewn end-to-side to incisions in the anterior aspect of the azygous
vein and the posterior aspect of the HV confluence. The original HV-PA
conduit was ligated with surgical clips but not divided. As shown in
Figure 5, postoperative computed tomography imaging demonstrated an
unobstructed conduit. Four years after pathway revision, this patient had
substantially improved symptoms and a saturation of 96% on room air,
up from 84% before pathway modification.
Patient 4
In patient 4, whose total cavopulmonary connection consisted of a right-
sided atriopulmonary connection and a BCPA using the single left-sided
SVC, the SVC-PA anastomosis was moved rightward. The original connec-
tion was taken down through a median sternotomy, the pulmonary arterio-
tomy was extended rightward, and a 19-mm ePFTE tube was used to
connect the single left SVC to the PA at the level of the atriopulmonary con-
nection. The patient was alive and well 13 years after pathway modifica-
tion, with an arterial oxygen saturation of 90% (compared with 85%FIGURE 1. In patient 1, the HV were baffled through a left lateral tunnel to the
amount of contrast can be seen filling but not passing across the hypoplastic cent
were dense and advanced PAVMs throughout the right lung (C). Central PA sten
hypoxemia. L, Left PA; HV, hepatic venous; R, right PA.
1364 The Journal of Thoracic and Cardiovascular Surbefore revision); no catheterization had been performed since revision to
assess the status of PAVMs.
Patient 5
In patient 5, an existing abnormality of the abdominal systemic venous
system was exploited to allow transcatheter conversion to an HV-azygous
circuit. After BCPA, the patient was found to have a duplicated IVC sys-
tem, with azygous continuation of an interrupted left IVC to a dominant
left SVC, and additional connection of a right-sided suprarenal IVC to the
floor of the right atrium after receiving the HVs (Figure 3). The 2 systems
were in communication at the level of the renal veins with a venous seg-
ment that was posterior to the descending aorta and anterior to the verte-
bral column and consequently had minor compression and obstruction.
The patient underwent Fontan completion with a 16-mm extracardiac
conduit from the HV to the right PA. After documentation of flow-
streaming and persistence of unilateral PAVMs, and evaluation of the cav-
opulmonary circulation during test occlusion of the HV-PA conduit, the
HV-PA conduit was completely occluded with an oversized Amplatzer
vascular plug II (AGA Medical, Inc, Plymouth, MN). After conduit occlu-
sion, HV flow passed through the prevertebral connecting vein into the
azygous with a 1 mm Hg HV-azygous vein gradient. Follow-up catheter-
ization 4 months later demonstrated resolution of PAVMs (Figure 3),
unobstructed return of HV blood to the azygous vein though the
pre-vertebral connecting vein and to both lungs, and a systemic arterialleft PA after prior BCPA, and A) HV flow streamed to the left lung. A small
ral PA segment (arrow). B, There were no PAVMs in the left lung, but there
ting facilitated HV flow to the right lung, but there was no improvement in
gery c June 2011
FIGURE 2. Patient 2 underwent total cavopulmonary connection without prior BCPA. A, HV flow flowed exclusively to the right lung, where therewere no
PAVMs. B, The azygous vein entered the left SVC (arrow indicates catheter passing from the azygous vein through the left SVC to the PAs), which was
connected to the PAs leftward of the HV-PA connection. C, There were diffuse left lung PAVMs, which (D) progressed over time and after placement of
a central PA stent (arrows). C, HV-PA conduit; R, right PA; HV, hepatic veins; L, left PA.
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Doxygen saturation of 96% on room air (compared with 86%
pre-modification). At most recent follow-up, 12 months after pathway
modification, systemic oxygen saturation by pulse oximetry was 97%
and exercise capacity was improved.
Patient 6
In patient 6, an HV-azygous vein connection was performed through
a right posterolateral thoracotomy without cardiopulmonary bypass. The
lower portion of the right-sided HV-PA conduit was dissected free and
a 16-mm ePTFE tube was used to connect this to the right-sided hemiazy-
gos vein almost exactly at the level where the hemiazygos crossed the
midline to the left azygous vein (which continued to the left SVC), with
end-to-side anastomoses to both the HV and azygous vein. The original
HV-PA conduit was ligated (but not divided) craniad to the new conduit us-
ing a combination of surgical clips and horizontal mattress sutures, Postop-
erative computed tomography demonstrated an unobstructed conduit
(Figure 5). Twenty-two months after pathway modification, this patient’s
saturations had improved to 91% from 80%, with improvement in exercise
tolerance and resolution of exercise-induced cyanosis.
Patient 7
Patient 7 had a lateral tunnel connection taken down through a median
sternotomy with cardiopulmonary bypass, followed by connection of the
HVand azygous vein with a 14-mm ePTFE conduit. The left-sized azygous
vein was exposed through an inferior posterior pericardiotomy, and the
conduit was connected end-to-side to both the azygous vein and the
right-sided HV confluence. At most recent follow-up, 2 months before
the preparation of this article, resting saturations were up from 75% toThe Journal of Thoracic and Car87% and exercise tolerancewas reportedly much improved with resolution
of exercise-exacerbated cyanosis.
Patient 8
Patient 8, in whom the right HV had not been incorporated into the orig-
inal HV-PA connection, had a 12-mm ePTFE conduit placed from the right
HV to the right-sided azygous vein, leaving the existing conduit from the
left HV to the left PA in situ (Figure 4). This patient also underwent coil
occlusion of large PAVMs. Flow from the right HV to the right PA was
documented by postoperative computed tomography, but the right lung
PAVMs were advanced. Hypoxemia persisted, renal failure ensued, and
the patient died 3.5 years after pathway modification.DISCUSSION
Newly Diagnosed or Persistent Unilateral Pulmonary
Arteriovenous Malformations After Total
Cavopulmonary Connection
We previously reported our experience with total cavopul-
monary connection in patients with heterotaxy, interrupted
IVC, and univentricular heart disease who had important
PAVMsafter aKawashimaprocedure.2 In that study,we found
that PAVMs typically resolved after incorporation of the HVs
into the cavopulmonary circuit, but that unilateral PAVMsper-
sisted in aminority of patients with streaming of flow from the
HVs exclusively to the ipsilateral PA. Similar findings havediovascular Surgery c Volume 141, Number 6 1365
FIGURE 3. Patient 5 underwent Fontan completion by connection of the HV to the right PAwith a 16-mm ePTFE conduit, which resulted in (A) streaming
of HV flow exclusively to the right lung. B, The azygous vein connected to the left-sided SVC, and there were unilateral left lung PAVMs. C, D, There was
also a duplicated IVC system with a connection between the HVand right-sided suprarenal IVC and between the IVC and azygous vein at the level of the
renal veins (arrow). D, After completion of the modified Fontan circulation, therewas no flow from the HVacross this connecting vein and a small amount of
flow from the azygous into the suprarenal right IVC. E, After occlusion of the HV-PA conduit with a vascular plug (arrows), HV flow passed down the
suprarenal IVC, across the connecting vein into the azygous vein. F, After this reconfiguration, left lung PAVMs resolved and systemic oxygen saturation
increased to 97%. C, HV-PA conduit; Az, azygous vein; L, left PA; V, IVC; HV, hepatic veins.
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Dbeen reported by others.3,16-18 As illustrated by 3 of the
patients in the current series and prior reports, unilateral
PAVMs may also manifest after Fontan completion as the
result of flow-streaming.5,19,20 Altogether, in our experience,
new or persistent PAVMs were found in 15% of patients (8
of 53) with this anatomy who underwent a Fontan
completion, with or without intermediate BCPA. This may
be an underestimate because some of the 53 patients were
not followed at our center after Fontan completion.
All of the patients with flow-streaming and unilateral
PAVMs in this series had separation between the PA inser-
tions of the HV pathway and the single or dominant SVC.
Kim and colleagues3 recently reported a similar pattern,
and Nakamura and colleagues5 observed new PAVMs after
total cavopulmonary connection in 6 of 16 patients, which
were associated with HV-SVC offset and unilateral HV
streaming in 5 patients.When the HVs enter the PAs laterally
offset from the SVC, or from the dominant SVC in patients
with bilateral SVCs, it is nearly inevitable that HV flow1366 The Journal of Thoracic and Cardiovascular Surwill distribute completely or primarily to the ipsilateral
lung.21,22 The SVC receiving azygous venous flow will
carry more than 50% of systemic venous return, even in
patients with bilateral SVCs, whereas the HVs tend to
carry 20% to 25%.23 Thus, unless there is high resistance
in the pulmonary vascular bed ipsilateral to the HV insertion,
there is unlikely to be amajor impetus forHVblood to pass to
the opposite lung (Figure 6). As the offset distance between
the SVC and HV connections to the PAs increases, so does
the likelihood of flow-streaming. Anterior-posterior offset
of the SVC-PA and HV-PA connections may also be an im-
portant consideration in establishing bilateral HV flow.24
As demonstrated in this series, reconfiguration of the cavo-
pulmonary pathway to direct HV blood to the affected lung is
often effective at improving hypoxemia due to unilateral
PAVMs after total cavopulmonary connection. In 2 patients,
interventions that successfully directed HV blood to the lung
with persistent PAVMs did not result in resolution of PAVMs
or hypoxemia. Both of these patients had very advanced andgery c June 2011
FIGURE 4. Patient 8 had a left-sided HV-PA conduit placed 6 years after bilateral BCPA. The right hepatic veins continued to drain to the atrium, and
intrahepatic collaterals (*) enlarged, allowing retrograde flow from the cavopulmonary circulation through HV-PA conduit, through the liver, and into
the atrium. A, The HV-atrial connection was closed with an occlusion device (arrow), but (B) streaming of HV flow to the left lung continued, and (C) right
lung PAVMs persisted and progressed to a dense, advanced state. Reconfiguration was performed by placing an additional ePTFE conduit from the right HV
to the right PA. RH, Right HV; L, left PA; C, HV-PA conduit; R, right PA.
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Dlong-standing PAVMs (Figures 1 and 4), and it is possible that
such malformations are beyond reversal. In 1 of them, the
existing conduit between the left HV and PAs was left open,
which may have had an adverse effect on flow through the
HV-azygous vein connection. The pathobiology of PAVM
formation and resolution is poorly understood, and the
hepatic factor hypothesis is based on circumstantial
evidence. The failure of PAVMs to resolve after introduction
of HV flow to the affected lung in these 2 patients highlights
the limitations of our understanding of this condition.
Cavopulmonary Pathway Configuration and
Reconfiguration
Given the mounting evidence that flow of HV blood to
the lungs is critical to prevent PAVMs after cavopulmonary
connection, particularly in patients with heterotaxy and left
isomerism, one of the top priorities in completing amodified
Fontan circulation in such patients should be constructing
a pathway that minimizes the chances of significant stream-
ing of HV flow toward 1 lung. This may be achieved (1) by
connecting the HVs and SVC to the PAs in close enough
proximity to facilitate mixing of SVC and HV blood and
consequently bilateral HV flow, or (2) by directing HV
blood into the systemic venous pathway upstream of the
systemic venous insertion into the PAs. Feasible options
and surgical approaches for creating such a pathway will
vary according to a number of anatomic factors, including
the number of SVCs; the number and location of separate
HV connections to the atrium; and relationships between
the HVs, SVC, azygous vein, descending aorta, ventricular
mass, and pulmonary veins. In the setting of a single SVC
that receives the azygous vein and is ipsilateral to the atrial
entrance of the HV, a standard lateral tunnel or extracardiac
conduit connection may provide a geometrically favorable
connection, whereas in other circumstances, constructionThe Journal of Thoracic and Carof an HV-PA connection that aligns with the SVC-PA anas-
tomosis may be awkward, and an HV-azygous vein connec-
tion may be optimal. If an HV-PA connection is used to
complete the Fontan circulation in patients with bilateral
SVCs, the connection should probably be juxtaposed to
the SVC that receives the most flow (ie, the SVC that re-
ceives the azygous vein). When Nakamura and colleagues5
observed a high frequency of new PAVMs after total cavo-
pulmonary connection in patients with IVC interruption,
they modified their technique for lateral tunnel or extracar-
diac Fontan completion in this patient population, eliminat-
ing lateral HV-SVC offset. Since adopting that change, they
have not encountered unilateral HV streaming or new
PAVMs after a modified Fontan connection.5
In patients with unilateral PAVMs due to HV flow-
streaming in an existing Fontan circulation, the question
is whether and how to revise the connection to achieve ad-
equate redistribution of HV blood to both lungs. In cases
with a stenotic segment of PA between the HV and SVC
connections to the PAs, stenting of the intervening segment
may improve HV blood flow to the contralateral lung. This
approach seemed to be successful in redistributing flow in 1
of our patients, but there was no resolution of hypoxemia 2
years later, presumably because of the advanced state of the
PAVMs. Although stenting the central PA does not correct
the offset between the HV-PA and SVC-PA connections,
qualitative assessment of changes in flow can be made im-
mediately, and assessment of the need for additional path-
way modifications made accordingly. Conceptually,
placing a graft from the existing HV-PA connection to the
affected PA makes sense, but attempts at constructing
a branched HV-PA conduit in 2 of our patients resulted in
acute thrombosis of the new conduit, presumably due at
least in part to stasis and competitive flow in the setting of
a large effective conduit volume carrying low flow at lowdiovascular Surgery c Volume 141, Number 6 1367
FIGURE 5. Post-modification computed tomography images in patients 3 (A–C) and 6 (D–F). Images in patient 3 demonstrate the HV-azygous vein con-
duit (C) in parasagittal (A) and paraxial (B) planes. A, C, Arrows indicate clips that were used to ligate the inferior portion of the HV-PA conduit (PC) above
the anastomosis of the HV-azygous vein conduit. The images in patient 6 demonstrate the connection between the HV-azygous vein conduit (C) and the prior
HV-PA conduit (O) in parasagittal (D) and axial (E) planes. In the coronal image (F), the midline connection between right-sided hemiazygous and left-sided
azygous veins is depicted with asterisks (**); the HV-azygous vein conduit can be seen near its entrance to the hemiazygous. Az, Azygous vein; C, HV-
azygous vein conduit; HV, hepatic veins; Ao, descending aorta; PC, HV-PA conduit; O, HV-PA conduit; H, hemiazygous vein; L, liver.
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Dvelocity and pressure.25 We no longer consider this a suit-
able approach. Similarly, ligation or division of the existing
HV-PA conduit may be an important element of facilitating
flow through the HV-azygous vein conduit and achieving
the ultimate goal of bilateral distribution of HV blood. Cre-
ation of a brachial arteriovenous fistula (or another form of
systemic-to-PA shunt) has not proven to be effective in pa-
tients with a Fontan connection of HV streaming, as dis-
cussed in a prior report.12 A strategy that is more likely to
redistribute HV flow effectively is rerouting of the HV path-
way either into the azygous vein, the PA at a point directly
opposite the SVC anastomosis, the innominate vein, or the
dominant SVC. Alternatively, the dominant SVC may be
rerouted to enter the PA opposite the HV-PA connection.
HV-azygous vein connection was performed in 5 of our
patients, and SVC rerouting was performed in 1 patient.
Of the various options for total cavopulmonary connec-
tion in patients with an interrupted IVC, HV-azygous vein1368 The Journal of Thoracic and Cardiovascular Surconnection may result in the most consistent venous mixing
and prevention of HV flow-streaming, in addition to
superior hydrodynamic efficiency.22,25 Compared with
rerouting the HV to the SVC or innominate vein, or
reconfiguring the prior SVC-PA anastomosis, an
HV-azygous vein connection may require less extensive
dissection to mobilize the critical vessels and a shorter
tube graft, which may be important considering the reported
propensity for thrombosis of HV-PA conduits in these pa-
tients.25 The surgical approach and pathway for the conduit
will vary according to various anatomic factors. Although it
may be more complicated to modify a previously created
HV-PA pathway than to create an HV-azygous vein connec-
tion as the initial Fontan connection, an existing HV-PA
conduit may also be used to advantage in the rerouting,
because the hepatic aspect of the conduit can be used in
the reconstruction, in effect extending the size of the HV
confluence and adding procedural flexibility. Severalgery c June 2011
FIGURE 6. Schematic diagrams of HVand PA flow-streaming and interactions in several representative forms of total cavopulmonary connection in pa-
tients with IVC interruption and direct atrial drainage of the HV. Solid arrows represent the distribution of azygous and SVC return, and dashed arrows
represent the distribution of HV return. A, There is contralateral offset of the single SVC-PA connection and the HV-PA connections, such that all HV return
is to a single lung. B, The single SVC and HV connect to the PAs without lateral offset, and there is HV flow to both lungs. C, There are bilateral SVCs and
connection of the HVs to the PA in proximity to the non-dominant SVC, which favors predominantly unilateral HV flow. D, With HV-azygous connection,
HV blood will enter the dominant SVC, which will provide well more than half of systemic venous inflow to the PAs. Flow from the HVs will distribute in
a similar fashion to azygous and SVC return, as depicted by the superimposed solid and dashed arrows. SVC, Superior vena cava; PA, pulmonary artery;
HV, hepatic venous.
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Dmodifications of HV-azygous vein connection in this popu-
lation have been described and depicted previously, some
of which are reprinted in Figure E1.9,17,26-28 In 3 of our
patients, a surgical HV-azygous connection was created
through a lateral thoracotomy without cardiopulmonary
bypass, which was facilitated by the presence of multiple
HVs (patient 8), a large hemiazygos that crossed the mid-
line at the level of the diaphragm (patient 6), or relatively
close location of the HV and azygous vein. In another pa-
tient (patient 7), the original Fontan connection was a mod-
ified lateral tunnel, so cardiopulmonary bypass through
a median sternotomy was necessary to convert that pathway
to an HV-azygous connection, and the azygous vein was ex-
posed through a posterior pericardiotomy. Given the vari-The Journal of Thoracic and Carous anatomic and prior operative factors that may
influence the pathway modification, precise preoperative
definition of the potentially relevant anatomic structures
is essential.
Amodeo and colleagues26 have proposed single-stage
HV-azygous vein connection along with BCPA in patients
with heterotaxy, interrupted IVC, and univentricular heart
disease. This approach ensures mixing and bilateral distri-
bution of HV blood and avoids a period of HVexclusion af-
ter BCPA. Although we continue to stage most patients with
an intermediate BCPA, our approach has evolved to the
point that we now consider HV-azygous vein connection
to be the preferred method of Fontan completion in this
patient population, provided there is favorable anatomy.diovascular Surgery c Volume 141, Number 6 1369
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DCONCLUSIONS
In patients with heterotaxy, polysplenia, an interrupted
IVC, and univentricular heart disease who have undergone
a Fontan procedure, new or persistent unilateral PAVMs due
to HV flow-streaming are relatively common and should be
considered when there is significant hypoxemia early or late
after Fontan completion. Resolution of hypoxemia after
cavopulmonary pathway reconfiguration in patients with
heterotaxy and post-Fontan HV flow-streaming provides
additional evidence in support of the hepatic factor hypoth-
esis for the pathogenesis of PAVMs and supports the prac-
tice of revising the cavopulmonary pathway in such
patients. Although various approaches may be effective
for configuring and reconfiguring the cavopulmonary path-
way in this patient population, direct HV-azygous vein con-
nection may provide the most reliable and predictable
mixing and bilateral distribution of HV blood, regardless
of PA, systemic venous, and HV anatomy. It is unknown
why PAVMs are more extensive in some patients or do
not resolve after effective delivery of HV effluent, but ear-
lier pathway rerouting in patients with established PAVMs
may optimize the likelihood of resolution.
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FIGURE E1. Pike and colleagues17 (A) and Steinberg and colleagues28 (B) depicted placement of a conduit from the right-sided HV to a contralateral
azygous vein. Kaneko and colleagues27 (C) connected widely spaced HVs, harvested with an atrial cuff, to the azygous vein with an autologous pericardial
roll. Az, Azygous vein; H, hepatic veins; V, vagus nerve; E, esophagus; and P, pericardial roll.
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